Replies to post #5564 on Capricor Therapeutics Inc (CAPR)

[GS1]

Most patients receiving CAP-1002 also showed improvements in inflammatory markers, though to varying degrees. Similar to other COVID-19 cohorts, our patients exhibited elevated cardiac troponin I and D-dimer levels [37, 44]. These biomarkers, however, decreased in all but 1 of the patients at the date of last follow-up.

D-Dimer is biomarker for blood clots.

https://link.springer.com/article/10.1007/s00395-020-0795-1